Literature DB >> 24707132

From conception to delivery: managing the pregnant inflammatory bowel disease patient.

Vivian W Huang1, Flavio M Habal1.   

Abstract

Inflammatory bowel disease (IBD) typically affects patients during their adolescent and young adult years. As these are the reproductive years, patients and physicians often have concerns regarding the interaction between IBD, medications and surgery used to treat IBD, and reproduction, pregnancy outcomes, and neonatal outcomes. Studies have shown a lack of knowledge among both patients and physicians regarding reproductive issues in IBD. As the literature is constantly expanding regarding these very issues, with this review, we provide a comprehensive, updated overview of the literature on the management of the IBD patient from conception to delivery, and provide action tips to help guide the clinician in the management of the IBD patient during pregnancy.

Entities:  

Keywords:  Biologics; Inflammatory bowel disease; Neonatal outcomes; Pregnancy

Mesh:

Substances:

Year:  2014        PMID: 24707132      PMCID: PMC3974516          DOI: 10.3748/wjg.v20.i13.3495

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  153 in total

Review 1.  American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy.

Authors:  Uma Mahadevan; Sunanda Kane
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

2.  Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries.

Authors:  K Fonager; H T Sørensen; J Olsen; J F Dahlerup; S N Rasmussen
Journal:  Am J Gastroenterol       Date:  1998-12       Impact factor: 10.864

3.  Diarrhoea due to 5-aminosalicylic acid in breast milk.

Authors:  G F Nelis
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

4.  Successful use of adalimumab (Humira) for Crohn's disease in pregnancy.

Authors:  Daniel S Mishkin; William Van Deinse; James M Becker; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

Review 5.  TNF-α and the development of the neonatal immune system: implications for inhibitor use in pregnancy.

Authors:  Razvan Arsenescu; Violeta Arsenescu; Willem J S de Villiers
Journal:  Am J Gastroenterol       Date:  2011-04       Impact factor: 10.864

6.  Azathioprine treatment during lactation.

Authors:  L A Christensen; J F Dahlerup; M J Nielsen; J F Fallingborg; K Schmiegelow
Journal:  Aliment Pharmacol Ther       Date:  2008-08-30       Impact factor: 8.171

7.  Further evidence for the involvement of prolactin in the inflammatory response.

Authors:  R Meli; O Gualillo; G M Raso; R Di Carlo
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

8.  Cyclosporine excretion into breast milk.

Authors:  Myla E Moretti; Michael Sgro; David W Johnson; Reg S Sauve; Mary J Woolgar; Anna Taddio; Zul Verjee; Esther Giesbrecht; Gideon Koren; Shinya Ito
Journal:  Transplantation       Date:  2003-06-27       Impact factor: 4.939

9.  Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.

Authors:  M Mogadam; W O Dobbins; B I Korelitz; S W Ahmed
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

10.  A population-based study of breastfeeding in inflammatory bowel disease: initiation, duration, and effect on disease in the postpartum period.

Authors:  Dana C Moffatt; Alexandra Ilnyckyj; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2009-06-23       Impact factor: 10.864

View more
  6 in total

Review 1.  A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy.

Authors:  Sherman Picardo; Cynthia H Seow
Journal:  Drugs       Date:  2019-07       Impact factor: 9.546

2.  Single Topic Conference on Autoimmune Liver Disease from the Canadian Association for the Study of the Liver.

Authors:  Aldo J Montano-Loza; Jessica R Allegretti; Angela Cheung; Maryam Ebadi; David Jones; Nanda Kerkar; Cynthia Levy; Sumera Rizvi; John M Vierling; Fernando Alvarez; Wayne Bai; Susan Gilmour; Aliya Gulamhusein; Orlee Guttman; Bettina E Hansen; Sonya MacParland; Andrew Mason; Fernanda Onofrio; Pere Santamaria; Ashley Stueck; Mark Swain; Catherine Vincent; Amanda Ricciuto; Gideon Hirschfield
Journal:  Can Liver J       Date:  2021-11-11

Review 3.  Management of Inflammatory Bowel Disease During Pregnancy.

Authors:  Ariella Bar-Gil Shitrit; Sorina Grisaru-Granovsky; Ami Ben Ya'acov; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-04-11       Impact factor: 3.199

4.  Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Alice Cheng; Andrew Cagan; Tianxi Cai; Vivian S Gainer; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Dig Dis Sci       Date:  2014-09-12       Impact factor: 3.199

Review 5.  Management of Eosinophilic Esophagitis During Pregnancy.

Authors:  Caitlin M Burk; Millie D Long; Evan S Dellon
Journal:  Dig Dis Sci       Date:  2016-02-18       Impact factor: 3.199

6.  Pharmacokinetics of monoclonal antibodies used for inflammatory bowel diseases in pregnant women.

Authors:  Rebecca H Stone; James Hong; Hyunyoung Jeong
Journal:  J Clin Toxicol       Date:  2014-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.